Form 4: United Therapeutics Director Tommy G. Thompson Exercises Options and Sells Shares
SEC Form 4
Director Tommy G. Thompson exercised stock options and sold shares of United Therapeutics Corp on February 28, 2025.
Summary
- On February 28, 2025, Tommy G. Thompson, a director of United Therapeutics Corporation, exercised stock options to acquire 2,500 shares of common stock at a price of $175.43 per share.
- Simultaneously, Thompson sold 2,500 shares of common stock at a price of $318.3351 per share.
- Following these transactions, Thompson directly owns 8,480 shares of common stock and indirectly owns 8,200 shares through a trust and 5,800 shares through a Family LLC.
- Thompson also holds 5,000 derivative securities (stock options).
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors. It's a standard practice for publicly traded companies and their executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a director.
- The impact is likely minimal as the number of shares involved is relatively small compared to the total outstanding shares of the company.
Key Dates
| Date | Description |
|---|---|
| 06/26/2016 | Date stock options became exercisable |
| July 7, 2023 | Vesting date of RSUs for which the reporting person elected to defer receipt of shares. |
| 02/28/2025 | Date of stock option exercise and stock sale |
| 03/03/2025 | Date of signature on the Form 4 filing |
| 06/26/2025 | Expiration date of stock options |
| July 8, 2026 | Date of issuance of 880 shares of common stock as the result of the July 7, 2023 vesting of RSUs |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.